These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2051845)

  • 21. Absorption-promoting adjuvants: animal studies on their effects on rectal drug absorption.
    Caldwell L; Nishihata T; Fix J; Selk S; Cargill R; Gardner CR; Higuchi T
    Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):503-7. PubMed ID: 6392793
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.
    Aungst BJ; Rogers NJ; Shefter E
    J Pharmacol Exp Ther; 1988 Jan; 244(1):23-7. PubMed ID: 3275772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
    Wang J; Tabata Y; Morimoto K
    J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
    Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
    Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microemulsions for improved peptide absorption from the gastrointestinal tract.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):205-20. PubMed ID: 2051845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic barriers to peptide and protein absorption.
    Lee VH
    Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal peptide delivery using colloidal carrier systems.
    Goebel A; Neubert RH
    Skin Pharmacol Physiol; 2008; 21(1):3-9. PubMed ID: 17912018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
    Lee HJ; Amidon GL
    NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
    [No Abstract]   [Full Text] [Related]  

  • 30. [Methodologies for regulation of intestinal absorption of biologically active peptides].
    Fujita T; Muranishi S
    Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improvement of transmucosal absorption of biologically active peptide drugs].
    Yamamoto A
    Yakugaku Zasshi; 2001 Dec; 121(12):929-48. PubMed ID: 11766407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
    Vyas SP; Venugopalan P; Sood A; Mysore N
    Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microemulsions as carriers for drugs and nutraceuticals.
    Spernath A; Aserin A
    Adv Colloid Interface Sci; 2006 Dec; 128-130():47-64. PubMed ID: 17229398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery systems for biopharmaceuticals.
    Davis SS
    J Pharm Pharmacol; 1992 Feb; 44 Suppl 1():186-90. PubMed ID: 1348281
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.